Who backs Treefrog Therapeutics?
21 investors| Investor | Type |
|---|---|
| Bpifrance | Other |
| La French Tech | Other |
| XAnge | Venture capital |
| BNP Paribas Développement | PE / buyout |
| IRDI Capital Investissement | PE / buyout |
| Siparex | PE / buyout |
| Bristol-Myers Squibb | — |
| AustralianSuper | Corporate |
| Leonard Green & Partners | PE / buyout |
| AQUITI Gestion | — |
| + 11 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Treefrog Therapeutics investors
21 investors are on record for Treefrog Therapeutics, including Bpifrance, La French Tech, XAnge and BNP Paribas Développement. By type, the record holds 4 private equity firms and 1 venture capital firm.
Free account
More of Treefrog Therapeutics with a free account
- ·The complete investor list: 21 names
- ·Watch Treefrog Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 21 firms already write checks for companies like Treefrog Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View